SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Genesis Healthcare, Inc. – ‘10-K’ for 12/31/18 – ‘EX-21’

On:  Monday, 3/18/19, at 3:49pm ET   ·   For:  12/31/18   ·   Accession #:  1558370-19-2231   ·   File #:  1-33459

Previous ‘10-K’:  ‘10-K’ on 3/16/18 for 12/31/17   ·   Next:  ‘10-K’ on 3/16/20 for 12/31/19   ·   Latest:  ‘10-K’ on 3/16/21 for 12/31/20   ·   1 Reference:  By:  SEC – ‘UPLOAD’ on 11/5/19

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/18/19  Genesis Healthcare, Inc.          10-K       12/31/18  118:19M                                    Toppan Merrill Bridge/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.14M 
 2: EX-21       Subsidiaries List                                   HTML     34K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML     32K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     41K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     41K 
 6: EX-32       Certification -- §906 - SOA'02                      HTML     38K 
13: R1          Document and Entity Information                     HTML     71K 
14: R2          Consolidated Balance Sheets                         HTML    173K 
15: R3          Consolidated Balance Sheets (Parentheticals)        HTML     59K 
16: R4          Consolidated Statements of Operations               HTML    110K 
17: R5          Consolidated Statements of Comprehensive Loss       HTML     50K 
18: R6          Consolidated Statements of Stockholders' Deficit    HTML     83K 
19: R7          Consolidated Statements of Cash Flows               HTML    142K 
20: R8          General Information                                 HTML     52K 
21: R9          Summary of Significant Accounting Policies          HTML     89K 
22: R10         Certain Significant Risks and Uncertainties         HTML     68K 
23: R11         Significant Transactions and Events                 HTML     84K 
24: R12         Net Revenues and Accounts Receivable                HTML    154K 
25: R13         Loss Per Share                                      HTML     86K 
26: R14         Segment Information                                 HTML    468K 
27: R15         Restricted Investments in Marketable Securities     HTML    162K 
28: R16         Property and Equipment                              HTML     88K 
29: R17         Goodwill and Identifiable Intangible Assets         HTML    121K 
30: R18         Long-Term Debt                                      HTML    159K 
31: R19         Leases and Lease Commitments                        HTML     74K 
32: R20         Financing Obligations                               HTML     55K 
33: R21         Stockholders' Deficit                               HTML     38K 
34: R22         Stock-Based Compensation                            HTML     72K 
35: R23         Income Taxes                                        HTML    171K 
36: R24         Related Party Transactions                          HTML     40K 
37: R25         Defined Contribution Plan                           HTML     34K 
38: R26         Other (Income) Loss                                 HTML     58K 
39: R27         Asset Impairment Charges                            HTML     46K 
40: R28         Assets Held for Sale                                HTML     53K 
41: R29         Commitments and Contingencies                       HTML     60K 
42: R30         Fair Value of Financial Instruments                 HTML    243K 
43: R31         Subsequent Events                                   HTML     37K 
44: R32         Summary of Significant Accounting Policies          HTML    120K 
                (Policies)                                                       
45: R33         Certain Significant Risks and Uncertainties         HTML     51K 
                (Tables)                                                         
46: R34         Loss Per Share (Tables)                             HTML     83K 
47: R35         Segment Information (Tables)                        HTML    471K 
48: R36         Restricted Investments in Marketable Securities     HTML    157K 
                (Tables)                                                         
49: R37         Property and Equipment (Tables)                     HTML     86K 
50: R38         Goodwill and Identifiable Intangible Assets         HTML    114K 
                (Tables)                                                         
51: R39         Long-term Debt (Tables)                             HTML    124K 
52: R40         Leases and Lease Commitments (Tables)               HTML     62K 
53: R41         Financing Obligations (Tables)                      HTML     51K 
54: R42         Stock-Based Compensation (Tables)                   HTML     66K 
55: R43         Income Taxes (Tables)                               HTML    151K 
56: R44         Other (Income) Loss (Tables)                        HTML     56K 
57: R45         Assets Held for Sale (Tables)                       HTML     54K 
58: R46         Fair Value of Financial Instruments (Tables)        HTML    234K 
59: R47         General Information (Details)                       HTML     56K 
60: R48         Summary of Significant Accounting Policies -        HTML     43K 
                Revenue recognition through Restricted Investments               
                (Details)                                                        
61: R49         Summary of Significant Accounting Policies - PP&E   HTML     44K 
                (Details)                                                        
62: R50         Summary of Significant Accounting Policies - New    HTML     58K 
                accounting pronouncements (Details)                              
63: R51         Certain Significant Risks and Uncertainties -       HTML     52K 
                Revenue Sources (Details)                                        
64: R52         Certain Significant Risks and Uncertainties -       HTML     81K 
                Concentration of Credit Risk (Details)                           
65: R53         Significant Transactions and Events -               HTML     94K 
                Restructuring Transactions (Details)                             
66: R54         Significant Transactions and Events - Divestiture   HTML    437K 
                of Non-Strategic Facilities (Details)                            
67: R55         Significant Transactions and Events - Acquisitions  HTML     52K 
                (Details)                                                        
68: R56         Significant Transactions and Events - Lease         HTML    172K 
                Amendments and Terminations (Details)                            
69: R57         Net Revenues and Accounts Receivable - Adoption of  HTML     54K 
                ASC 606 (Details)                                                
70: R58         Net Revenues and Accounts Receivable -              HTML     98K 
                Disaggregation (Details)                                         
71: R59         Loss Per Share - Calculation of Basic (Details)     HTML     68K 
72: R60         Loss Per Share - Antidilutive Securities (Details)  HTML     52K 
73: R61         Segment Information - Segment Reporting (Details)   HTML    197K 
74: R62         Segment Information - Assets and Goodwill by        HTML     42K 
                Segment (Details)                                                
75: R63         Restricted Investments in Marketable Securities -   HTML     59K 
                Components (Details)                                             
76: R64         Restricted Investments in Marketable Securities     HTML     51K 
                (Details)                                                        
77: R65         Restricted Investments in Marketable Securities -   HTML     66K 
                Maturities (Details)                                             
78: R66         Property and Equipment (Details)                    HTML     51K 
79: R67         Property and Equipment - Divestitures and           HTML     72K 
                Impairment (Details)                                             
80: R68         Goodwill and Identifiable Intangible Assets -       HTML     53K 
                Changes in carrying value of goodwill (Details)                  
81: R69         Goodwill and Identifiable Intangible Assets -       HTML     49K 
                Intangible Assets (Details)                                      
82: R70         Goodwill and Identifiable Intangible Assets         HTML     60K 
                (Details)                                                        
83: R71         Long-Term Debt (Details)                            HTML     65K 
84: R72         Long-Term Debt - New Asset Based Lending            HTML    113K 
                Facilities (Details)                                             
85: R73         Long-Term Debt - Revolving Credit Facilities        HTML     55K 
                (Details)                                                        
86: R74         Long-Term Debt - Term Loan Agreement (Details)      HTML     80K 
87: R75         Long-Term Debt - Real Estate Loans (Details)        HTML    107K 
88: R76         Long-Term Debt - HUD Insured Loans (Details)        HTML     74K 
89: R77         Long-Term Debt - Notes Payable (Details)            HTML     75K 
90: R78         Long-Term Debt - Other (Details)                    HTML     46K 
91: R79         Long-Term Debt - Debt Covenants (Details)           HTML     47K 
92: R80         Lease and Lease Commitments - Future minimum        HTML     85K 
                payment tables (Details)                                         
93: R81         Lease and Lease Commitments - Capital Lease Rates   HTML     52K 
                and Deferred Balances (Details)                                  
94: R82         Financing Obligations (Details)                     HTML     75K 
95: R83         Stockholders’ Deficit (Details)                     HTML     53K 
96: R84         Stock-Based Compensation (Details)                  HTML     53K 
97: R85         Stock-Based Compensation - Nonvested Units          HTML     73K 
                Activity (Details)                                               
98: R86         Income Taxes - Total Tax Provision (Details)        HTML     46K 
99: R87         Income Taxes - Components of Income Tax Provision   HTML     53K 
                (Details)                                                        
100: R88         Income Taxes - Tax Cuts And Jobs Act (Details)      HTML     43K  
101: R89         Income Taxes - Reconciliation of Income Tax         HTML     60K  
                Expense (Details)                                                
102: R90         Income Taxes - Deferred Income Taxes (Details)      HTML     66K  
103: R91         Income Taxes - Unrecognized Tax Benefits (Details)  HTML     50K  
104: R92         Income Taxes - Exchange Rights and Tax Receivable   HTML     39K  
                Agreement (Details)                                              
105: R93         Related Party Transactions (Details)                HTML     88K  
106: R94         Defined Contribution Plan (Details)                 HTML     32K  
107: R95         Other (Income) Loss (Details)                       HTML     50K  
108: R96         Asset Impairment Charges (Details)                  HTML     57K  
109: R97         Assets Held for Sale (Details)                      HTML     91K  
110: R98         Commitments and Contingencies - Self Insurance      HTML     50K  
                Risks (Details)                                                  
111: R99         Commitments and Contingencies - Litigation          HTML     63K  
                (Details)                                                        
112: R100        Fair Value of Financial Instruments - Recurring     HTML     56K  
                measures (Details)                                               
113: R101        Fair Value of Financial Instruments - Debt          HTML     63K  
                Instruments (Details)                                            
114: R102        Fair Value of Financial Instruments - Nonrecurring  HTML     49K  
                measures (Details)                                               
115: R103        Subsequent Events (Details)                         HTML     77K  
117: XML         IDEA XML File -- Filing Summary                      XML    219K  
116: EXCEL       IDEA Workbook of Financial Reports                  XLSX    163K  
 7: EX-101.INS  XBRL Instance -- gen-20181231                        XML   5.14M 
 9: EX-101.CAL  XBRL Calculations -- gen-20181231_cal                XML    312K 
10: EX-101.DEF  XBRL Definitions -- gen-20181231_def                 XML   1.54M 
11: EX-101.LAB  XBRL Labels -- gen-20181231_lab                      XML   2.66M 
12: EX-101.PRE  XBRL Presentations -- gen-20181231_pre               XML   2.10M 
 8: EX-101.SCH  XBRL Schema -- gen-20181231                          XSD    370K 
118: ZIP         XBRL Zipped Folder -- 0001558370-19-002231-xbrl      Zip    363K  


‘EX-21’   —   Subsidiaries List


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Ex21  

 

Exhibit 21

 

Subsidiaries of Registrant(1)

 

 

 

 

 

Subsidiary(2)

 

(Name under which subsidiary does business)

State of Incorporation or Organization

FC-GEN Operations Investment LLC

Delaware

Genesis Administrative Services LLC

Delaware

Genesis Eldercare Rehabilitation Services LLC

Delaware

GHC Holdings LLC

Delaware

SHG Resources, LLC

Delaware

Summit Care, LLC

Delaware

SunBridge Healthcare LLC

New Mexico

 

 

 

(1) Subsidiaries for purposes of this Exhibit 21 include corporations, limited liability companies and limited partnerships directly or indirectly wholly owned by Genesis Healthcare, Inc.

 

(2)  Names of subsidiaries that, considered in the aggregate as a single subsidiary, would not constitute a “significant subsidiary” (as defined in Rule 1-02(w) of Regulation S-X) as of December 31, 2018, are omitted.

 

 



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/18/198-K
For Period end:12/31/184
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/05/19  SEC                               UPLOAD12/04/19    2:39K  Genesis Healthcare, Inc.
Top
Filing Submission 0001558370-19-002231   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 9:47:10.1am ET